$257.50
1.39% today
NYSE, Nov 03, 09:45 pm CET
ISIN
US50540R4092
Symbol
LH

Laboratory Stock price

$253.96
-33.10 11.53% 1M
+12.95 5.37% 6M
+24.64 10.74% YTD
+25.69 11.25% 1Y
+63.37 33.25% 3Y
+75.93 42.65% 5Y
+147.04 137.52% 10Y
+212.51 512.69% 20Y
NYSE, Closing price Fri, Oct 31 2025
+1.63 0.65%

Key metrics

Basic
Market capitalization
$21.1b
Enterprise Value
$26.2b
Net debt
$5.1b
Cash
$598.1m
Shares outstanding
83.0m
Valuation (TTM | estimate)
P/E
24.9 | 15.1
P/S
1.5 | 1.5
EV/Sales
1.9 | 1.8
EV/FCF
18.9
P/B
2.4
Dividends
DPS
$2.88
Yield 1Y | 5Y
1.1% | 0.9%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
32.6% | 26.9%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$13.8b | $14.4b
EBITDA
$1.6b | $2.5b
EBIT
$1.4b | $2.0b
Net Income
$855.2m | $1.4b
Free Cash Flow
$1.4b
Growth (TTM | estimate)
Revenue
8.3% | 10.9%
EBITDA
18.9% | 78.7%
EBIT
20.1% | 79.0%
Net Income
96.4% | 87.0%
Free Cash Flow
63.8%
Margin (TTM | estimate)
Gross
28.5%
EBITDA
11.9% | 17.3%
EBIT
9.9%
Net
6.2% | 9.7%
Free Cash Flow
10.0%
Financial Health
Equity Ratio
43.8%
Return on Equity
9.3%
ROCE
8.7%
ROIC
6.4%
Debt/Equity
0.6
More
EPS
$10.2
FCF per Share
$16.6
Short interest
3.8%
Employees
65k
Rev per Employee
$200.0k
Show more

Is Laboratory a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Laboratory Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Laboratory forecast:

24x Buy
83%
5x Hold
17%

Analyst Opinions

29 Analysts have issued a Laboratory forecast:

Buy
83%
Hold
17%

Financial data from Laboratory

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
13,765 13,765
8% 8%
100%
- Direct Costs 9,850 9,850
7% 7%
72%
3,916 3,916
10% 10%
28%
- Selling and Administrative Expenses 2,273 2,273
5% 5%
17%
- Research and Development Expense - -
-
-
1,643 1,643
19% 19%
12%
- Depreciation and Amortization 278 278
13% 13%
2%
EBIT (Operating Income) EBIT 1,365 1,365
20% 20%
10%
Net Profit 855 855
96% 96%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Laboratory directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Laboratory Stock News

Neutral
Seeking Alpha
6 days ago
Labcorp Holdings Inc. (NYSE:LH ) Q3 2025 Earnings Call October 28, 2025 9:00 AM EDT Company Participants Christin O'Donnell - Vice President of Investor Relations Adam Schechter - President, CEO & Chairman Julia Wang - CFO & Executive VP Conference Call Participants Lisa Gill - JPMorgan Chase & Co, Research Division Michael Cherny - Leerink Partners LLC, Research Division Jack Meehan - Nephron ...
Positive
Reuters
6 days ago
Labcorp on Tuesday raised its annual profit forecast and beat estimates in the third quarter as the laboratory operator benefited from strong demand for its diagnostic tests.
Neutral
PRNewsWire
6 days ago
Updates Full-Year Guidance Financial results from Operations for third quarter 2025 versus third quarter 2024: Revenue: $3.56 billion versus $3.28 billion Diluted EPS: $3.12 versus $2.00 Adjusted EPS: $4.18 versus $3.50 Updated Full-Year Enterprise Revenue, Adjusted EPS and Free Cash Flow guidance: Revenue guidance of 7.4% to 8.0%; midpoint lowered 40 bps due to currency and acquisition timing ...
More Laboratory News

Company Profile

Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Head office United States
CEO Adam Schechter
Employees 65,450
Founded 1971
Website www.labcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today